ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Urology |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2022;volume=38;issue=3;spage=238;epage=239;aulast=Kumar |